Novel Heterocyclic Analogues of the HIV‐1 Protease Inhibitor, Ritonavir

References

• Vacca , J. P. and Condra , J. H. 1997 . Clinically effective HIV‐1 protease inhibitors . Drug Discov. Today , 2 : 261 – 272 . [CSA]
   Web of Science ®Google Scholar
• Huff , J. R. 1991 . HIV protease: a novel chemotherapeutic target for AIDS . J. Med. Chem. , 34 : 2305 – 2314 . [PUBMED] [INFOTRIEVE] [CSA]
   PubMed Web of Science ®Google Scholar
• DeLucca , G. V. , Liang , J. , Aldrich , P. E. , Calabrese , J. , Cordova , B. , Klabe , R. M. , Rayner , M. M. and Chang , C.‐H. 1997 . Design, synthesis, and evaluation of tetrahydropyrimidinones as an example of a general approach to nonpeptide HIV protease inhibitors . J. Med. Chem. , 40 : 1707 – 1719 . [CSA] [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Brik , A. and Wong , C.‐H. 2003 . HIV‐1 protease: mechanism and drug discovery . Org. Biomol. Chem. , 1 : 5 – 14 . [PUBMED] [INFOTRIEVE] [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Ghosh , A. K. , Shin , D. and Mathivanan , P. 1999 . Asymmetric dihydroxylation route to a dipeptide isostere of a protease inhibitor: enantioselective synthesis of the core unit of ritonavir . Chem. Commun. , : 1025 – 1026 . [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Dorsey , B. D. , Levin , R. B. , McDaniel , S. L. , Vacca , J. P. , Guare , J. P. , Darke , P. L. , Zugay , J. A. , Emini , E. A. , Schleif , W. A. , Quintero , J. C. , Lin , J. H. , Chen , I.‐W. , Holloway , M. K. , Fitzgerald , P. M.D. , Axel , M. G. , Ostovic , D. , Anderson , P. S. and Huff , J. R. 1994 . L‐735,524: The design of a potent and orally bioavailable HIV protease inhibitor . J. Med. Chem. , 37 : 3443 – 3451 . [PUBMED] [INFOTRIEVE] [CSA]
   PubMed Web of Science ®Google Scholar
• D'Aniello , F. and Taddei , M. 1992 . A stereoselective method for the preparation of HIV‐1 protease inhibitors based on the Lewis acid mediated reaction of allylsilanes and N‐Boc‐α‐amino aldehydes . J. Org. Chem. , 57 : 5247 – 5250 .
   Web of Science ®Google Scholar
• Drewe , J. , Gutmann , H. , Fricker , G. , Török , M. , Beglinger , C. and Huwyler , J. 1999 . HIV protease inhibitor ritonavir: a more potent inhibitor of P‐glycoprotein than the cyclosporine analog SDZ PSC 833 . Biochem. Pharm. , 57 : 1147 – 1152 . [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Kaye , P. T. , Nchinda , A. T. , Sabbagh , L. V. and Bacsa , J. 2003 . Chromone studies. Part 14. Unprecedented dimerisation of chromone‐3‐carbaldehyde‐derived Baylis–Hillman adducts . J. Chem. Res. (S) , : 111 – 113 . J. Chem. Res. (M), 2003, 301–318 (and references cited therein)[CSA]
   Web of Science ®Google Scholar
• Kaye , P. T. and Musa , M. A. 2003 . Efficient and chemoselective access to 3‐(chloromethyl)coumarins via direct cyclisation of unprotected Baylis–Hillman adducts . Synthesis , : 531 – 534 . (and references cited therein)[CROSSREF]
   Web of Science ®Google Scholar
• Kaye , P. T. and Nocanda , X. W. 2000 . Application of Baylis–Hillman methodology in a chemoselective synthesis of 2H‐1‐chromenes . J. Chem. Soc., Perkin Trans. 1 , : 1331 – 1332 . [CROSSREF]
   Google Scholar
• Kaye , P. T. and Nocanda , X. N. 2001 . Baylis–Hillman synthesis of 3‐substituted 2H‐1‐benzothiopyrans . Synthesis , : 2389 – 2392 . [CROSSREF]
   Google Scholar
• Brinkworth , R. I. , Stoermer , M. J. and Fairlie , D. P. 1992 . Flavones are inhibitors of HIV‐1 proteinase . Biochem. Biophys. Res. Commun. , 188 : 631 – 637 . [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Hariprasad , V. , Talele , T. T. and Kulkarni , V. M. 1998 . Design and synthesis of a novel series of nonpeptidic HIV‐1 protease inhibitors . Pharm. Pharmacol. Commun. , 4 : 365 – 372 . [CSA]
   Google Scholar
• Stuk , T. L. , Haight , A. R. , Scarpetti , D. , Allen , M. S. , Menzia , J. A. , Robbins , T. A. , Parekh , S. I. , Langridge , D. C. , Tien , J.‐H. J. , Pariza , R. J. and Kerdesky , F. A.J. 1994 . An efficient stereocontrolled strategy for the synthesis of hydroxyethylene dipeptide isosteres . J. Org. Chem. , 59 : 4040 – 4041 .
   Web of Science ®Google Scholar
• Ellis , G. P. and Thomas , I. L. 1974 . Benzopyrones. XI. 3‐Substituted 4‐oxochromen‐2‐carboxylic acid derivatives . J. Chem. Soc., Perkin Trans. 1 , : 2570 – 2574 . [CROSSREF]
   Google Scholar
• Fitton , A. O. and Smalley , R. K. 1968 . Practical Heterocyclic Chemistry 95 London : Academic Press .
   Google Scholar
• March , J. 1992 . Advanced Organic Chemistry , 4th Ed. 395 – 396 . New York : Wiley .
   Google Scholar
• Ghosh , A. K. , McKee , S. P. , Thompson , W. J. , Darke , P. L. and Zugay , J. C. 1993 . Potent HIV‐1 protease inhibitors: stereoselective synthesis of a dipeptide mimic . J. Org. Chem. , 58 : 1025 – 1029 .
   PubMed Web of Science ®Google Scholar
• Musa , M. A. 2003 . Rhodes University . Ph.D. Thesis
   Google Scholar
• Kaye , P. T. and Nocanda , X. W. 2002 . J. Chem. Soc., Perkin Trans. 1 , : 1318 – 1323 . [CROSSREF]
   Google Scholar
• Robbins , M. D. and Vaughan , H. L. 1975 . Rapid procedure for the hydrolysis of amides to acids . J. Org. Chem. , 40 : 1187 – 1189 .
   Web of Science ®Google Scholar
• Kempf , D. J. , Marsh , K. C. , Denissen , J. F. , McDonald , E. , Vasavanonda , S. , Flentge , C. A. , Green , B. E. , Fino , L. , Park , C. H. and Kong , X. P. 1995 . ABT‐538 is a potent inhibitor of human immunodeficiency virus protease and has high oral bioavailability in humans . Proc. Natl. Acad. Sci. , 92 : 2484 – 2488 . [PUBMED] [INFOTRIEVE] [CSA]
   PubMed Web of Science ®Google Scholar
• De Lucca , G. V. , Viitanen , S. E. and Lam , P. Y.S. 1997 . Cyclic HIV protease inhibitors capable of displacing the active site structural water molecule . Drug Discov. Today , 2 : 6 – 18 . [CSA] [CROSSREF]
   Web of Science ®Google Scholar
• Jadhav , P. K. , Ala , P. , Woerner , F. J. , Chang , C. H. , Garber , S. S. , Anton , E. D. and Bacheler , L. T. 1997 . Cyclic urea amides: HIV‐1 protease inhibitors with low nanomolar potency against both wild type and protease inhibitor resistant mutants of HIV . J. Med. Chem. , 40 : 181 – 191 . [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Thaisrivongs , S. , Watenpaugh , K. D. , Howe , W. J. , Tomich , P. K. , Dolak , L. A. , Chong , K. T. , Tomich , C. S.C. , Tomasselli , A. G. , Turner , S. R. , Strohbach , J. W. , Mulichak , A. M. , Janakiraman , M. N. , Moon , J. B. , Lynn , J. C. , Horng , M. M. , Hinshaw , R. R. , Curry , K. A. and Rothrock , D. J. 1995 . Structure‐based design of novel HIV protease inhibitors: carboxamide‐containing 4‐hydroxycoumarins and 4‐hydroxy‐2‐pyrones as potent nonpeptidic inhibitors . J. Med. Chem. , 38 : 3624 – 3637 . [PUBMED] [INFOTRIEVE] [CSA]
   PubMed Web of Science ®Google Scholar
• Kaye , P. T. and Musa , M. A. 2002 . Synthesis , : 2701 – 2706 . [CROSSREF]
   Web of Science ®Google Scholar
• Drewes , S. E. , Njamela , O. L. , Emslie , N. D. , Ramesar , N. and Field , J. S. 1993 . Intramolecular Baylis–Hillman reaction: a pathway to substituted coumarins . Synth. Commun. , 23 ( 20 ) : 2807 – 2815 .
   Web of Science ®Google Scholar
• Mouysset , G. , Payard , M. , Grassy , G. , Tronche , P. , Dabire , H. , Mouille , P. and Schmitt , H. 1987 . Pharmacomodulation of α‐adrenergic blocking agents by a series of benzopyrans . Eur. J. Med. Chem. , 22 : 539 – 544 . (Chem. Abstr. 109:92718)[CROSSREF]
   Web of Science ®Google Scholar
• Gupta , R. C. , Pratap , R. , Prasad , C. R. and Anand , N. 1982 . Chromene‐ and chroman‐3‐carboxamides and some related compounds as a new class of centrally acting agents . Ind. J. Chem., Section B: Organic Chemistry Including Medicinal Chemistry , 21B ( 4 ) : 344 – 347 . (Chem. Abstr. 98, 16543)
   Google Scholar